journal article·2021-06-20Open access

Neuronutraceuticals Modulate Lipopolysaccharide- or Amyloid-β 1-42 Peptide-Induced Transglutaminase 2 Overexpression as a Marker of Neuroinflammation in Mouse Microglial Cells

Nicola Gaetano Gatta, Andrea Parente, Francesca Guida, Sabatino Maione, Vittorio Gentile

Applied Sciences· Volume 11· Issue 12

Abstract

Background: Tissue type 2 transglutaminase (TG2, E.C. 2.3.2,13) is reported to be involved in the phagocytosis of apoptotic cells in mouse microglial BV2 cells and peripheral macrophages. In this study, by using lipopolysaccharide (LPS)- or amyloid-β 1-42 (Aβ 1-42) peptide-stimulated microglial cell line BV2 and mouse primary microglial cells, we examined the effects of different neuronutraceutical compounds, such as curcumin (Cu) and N-Palmitoylethanolamine (PEA), known for their anti-inflammatory activity, on TG2 and several inflammatory or neuroprotective biomarker expressions. Methods: Mouse BV2 cells were treated with LPS or Aβ1-42 in the presence of curcumin or PEA, in order to evaluate the expression of TG2 and other inflammatory or neuroprotective markers using Real Time-PCR and Western blot analyses. Results: Curcumin and PEA were capable of reducing TG2 expression in mouse microglial cells during co-treatment with LPS or Aβ 1-42. Conclusions: The results show the role of TG2 as an important marker of neuroinflammation and suggest a possible use of curcumin and PEA in order to reduce LPS- or Aβ1-42-induced TG2 overexpression in mouse microglial cells.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Blood properties and coagulation · Adipokines, Inflammation, and Metabolic Diseases · Neuroinflammation and Neurodegeneration Mechanisms

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Departments of Precision Medicine, University of Campania “L. Vanvitelli”, via de Crecchio 7, 80138 Naples, Italy

Department of Experimental Medicine, University of Campania “L. Vanvitelli”, via de Crecchio 7, 80138 Naples, Italy

IRCSS, Neuromed, 86077 Pozzilli, Italy

Funding

Regione Campania

References (34)

Show source-provided references
2. Transglutaminases
3. Differential expression of tissue transglutaminase in human cells: An immunohistochemical study10.1007/BF00229084 ↗
4. Induction and activation of tissue transglutaminase during programmed cell death10.1016/0014-5793(87)80430-1 ↗
5. “Tissue” transglutaminase is specifically expressed in neonatal rat liver cells undergoing apoptosis upon epidermal growth factor stimulation10.1007/BF00318764 ↗
6. Apoptosis: Molecular mechanisms in programmed cell death
7. Formation of N-ε−(γ-glutamyl)-lysine isodipeptide in chinese hamster ovary cells10.1042/bj2630843 ↗
8. Tissue transglutaminase and apoptosis: Sense and antisense transfection studies with human neuroblastoma cells
9. Identification of a substrate site for liver transglutaminase on the aminopropeptide of type III collagen10.1016/S0021-9258(19)75743-3 ↗
10. Subcellular localization and a large molecular weight substrate for the liver plasma membrane transglutaminase10.1016/S0021-9258(17)35804-0 ↗
11. Fibronectin is a component of the sodium dodecyl sulfate-insoluble transglutaminase substrate10.1016/S0021-9258(18)68500-X ↗
12. Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration10.1083/jcb.102.3.679 ↗
13. Formation of high weight dermatan sulfate proteoglycan in bovine aortic endothelial cell cultures10.1016/S0021-9258(18)38247-4 ↗
14. Transglutaminase-sensitive glutamine residues of human plasma fibronectin revealed by studying its proteolytic fragments10.1111/j.1432-1033.1986.tb09407.x ↗
15. Transglutaminase-mediated cross-linking of fibrinogen by human umbilical vein endothelial cells10.1016/S0021-9258(19)47090-7 ↗
16. Vitronectin in the substratum of endothelial cells is cross-linked and phosphorylated10.1016/0006-291X(91)91439-J ↗
17. Expression of tissue transglutaminase in Balb-C 3T3 fibroblasts: Effects on cellular morphology and adhesion10.1083/jcb.119.2.463 ↗
18. Zhang, J., Wang, S., Huang, W., and Bennett, D.A. (2015). Tissue transglutaminase and its product isopeptide are increased in Alzheimer’s disease and APPswe/PS1dE9 double transgenic mice brains. Mol. Neurobiol.10.1007/s12035-015-9413-x ↗
19. Wilhelmus, M.M., de Jager, M., Smit, A.B., van der Loo, R.J., and Drukarch, B. (2016). Catalytically active tissue transglutaminase colocalises with Aβ pathology in Alzheimer’s disease mouse models. Sci. Rep.10.1038/srep20569 ↗
20. Transglutaminase 2 and neuroinflammation10.1007/s00726-014-1864-2 ↗
21. Curcumin: A potential cancer chemopreventive agent through suppressing NF-kB signaling
22. Transglutaminase 2 induces nuclear factor-kB activation via a novel pathway in BV-2 microglia10.1074/jbc.M407627200 ↗
23. Kumar, S., and Mehta, K. (2012). Tissue transglutaminase constitutively activates HIF-1a promoter and nuclear factor-kB via a non-canonical pathway. PLoS ONE, 7.10.1371/journal.pone.0049321 ↗
24. Isolation and characterization of the human tissue transglutaminase promoter10.1074/jbc.270.17.9748 ↗
25. Curcumin (Diferulolylmethane) reduces transglutaminase 2 overexpression induced by retinoic acid in human nervous cell lines10.1159/000448998 ↗
26. Alessio, N., Belardo, C., Trotta, M.C., Paino, S., Boccella, S., Gargano, F., Pieretti, G., Ricciardi, F., Marabese, I., and Luongo, L. (2021). Vitamin D Deficiency Induces Chronic Pain and Microglial Phenotypic Changes in Mice. Int. J. Mol. Sci., 22.10.3390/ijms22073604 ↗
27. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction10.1016/0003-2697(87)90021-2 ↗
28. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method10.1006/meth.2001.1262 ↗
29. Analyzing real-time PCR data by the comparative C(T) method10.1038/nprot.2008.73 ↗
30. Exploring the full spectrum of macrophage activation10.1038/nri2448 ↗
31. Monocyte and macrophage heterogeneity10.1038/nri1733 ↗
32. Palmitoylethanolamide induces microglia changes associated with increased migration and phagocytic activity: Involvement of the CB2 receptor10.1038/s41598-017-00342-1 ↗
33. Palmitoylethanolamide Reduces Neuropsychiatric Behaviors by Restoring Cortical Electrophysiological Activity in a Mouse Model of Mild Traumatic Brain Injury10.3389/fphar.2017.00095 ↗
34. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide10.1124/mol.104.006353 ↗